Suppr超能文献

外周静脉导管失败:11830 个导管风险的二次分析。

Peripheral intravenous catheter failure: A secondary analysis of risks from 11,830 catheters.

机构信息

Alliance for Vascular Access Teaching and Research, Menzies Health Institute Queensland, Brisbane, QLD, Australia; Nursing and Midwifery Research Centre, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; School of Nursing and Midwifery, Griffith University, Brisbane, Queensland, Australia; School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia; School of Nursing, Midwifery and Social Work, University of Queensland, Brisbane, Queensland, Australia.

Alliance for Vascular Access Teaching and Research, Menzies Health Institute Queensland, Brisbane, QLD, Australia; Nursing and Midwifery Research Centre, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; School of Nursing and Midwifery, Griffith University, Brisbane, Queensland, Australia; Queensland Children's Hospital, Brisbane, Queensland, Australia; Nursing Practice Development Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

出版信息

Int J Nurs Stud. 2021 Dec;124:104095. doi: 10.1016/j.ijnurstu.2021.104095. Epub 2021 Sep 26.

Abstract

BACKGROUND

Peripheral intravenous catheters are an essential medical device which are prone to complications and failure.

OBJECTIVES

Identify patient, provider and device risk factors associated with all-cause peripheral intravenous catheter failure as well as individual complications: phlebitis, infiltration/occlusion, and dislodgement to improve patient outcomes.

DESIGN

Secondary analysis of twelve prospective studies performed between 2008 and 2020.

SETTINGS

Australian metropolitan and regional hospitals including one paediatric hospital.

PARTICIPANTS

Participants were from medical, surgical, haematology, and oncology units.

METHODS

Multilevel mixed-effects parametric survival regression was used to identify factors associated with all-cause peripheral intravenous catheter failure, phlebitis, occlusion/infiltration, and dislodgement. We studied patient (e.g., age, gender), device (e.g., gauge), and provider (e.g., inserting clinician) variables. Stepwise regression involved clinically and p<0.20 significant variables entered into the multivariable model. Results were expressed as hazard ratios (HRs) and 95% confidence intervals (CI); p<0.01 was considered statistically significant.

RESULTS

Of 11,830 peripheral intravenous catheters (8,200 participants) failure occurred in 36% (n = 4,263). Occlusion/infiltration incidence was 23% (n = 2,767), phlebitis 12% (n = 1,421), and dislodgement 7% (n = 779) of catheters. Patient factors significantly associated with failure and complications were: female gender (phlebitis; (HR 1.98, 95% CI 1.72-2.27), (infiltration/occlusion; HR 1.45, 95% CI 1.33-1.58), (failure; HR 1.36, 95% CI 1.26-1.46); and each year increase in age (phlebitis; 0.99 HR, 95% CI 0.98-0.99), (failure; 0.99 HR, 95% CI 0.99-0.99). The strongest provider risk factor was intravenous antibiotics (infiltration/occlusion; HR 1.40, 95% CI 1.27-1.53), (phlebitis; HR 1.36, 95% CI 1.18-1.56), (failure; HR 1.26, 95% CI 1.17-1.36). Catheters inserted by vascular access teams were less likely to dislodge (HR 0.53, 95% CI 0.42-0.67). Device risk factors most associated with all-cause failure were wrist/hand (HR 1.34, 95% CI 1.23-1.46), antecubital fossa peripheral intravenous catheters (HR 1.29, 95% CI 1.16-1.44) and 22/24 gauge (HR 1.27, 95% CI 1.12-1.45) catheters.

CONCLUSION

Factors identified, including the protective aspect of vascular access team insertion, and high catheter failure associated with intravenous antibiotic administration, will allow targeted updates of peripheral intravenous catheter guidelines and models of care.

摘要

背景

外周静脉导管是一种重要的医疗器械,容易发生并发症和故障。

目的

确定与外周静脉导管所有原因失败以及个别并发症(静脉炎、渗透/阻塞和脱落)相关的患者、提供者和设备风险因素,以改善患者的预后。

设计

对 2008 年至 2020 年期间进行的 12 项前瞻性研究进行二次分析。

地点

澳大利亚的大都市和地区医院,包括一家儿科医院。

参与者

参与者来自内科、外科、血液科和肿瘤科。

方法

使用多级混合效应参数生存回归来确定与外周静脉导管所有原因失败、静脉炎、阻塞/渗透和脱落相关的因素。我们研究了患者(如年龄、性别)、设备(如测量)和提供者(如插入临床医生)的变量。逐步回归涉及临床和 p<0.20 有意义的变量,这些变量被输入多变量模型。结果表示为风险比(HRs)和 95%置信区间(CI);p<0.01 被认为具有统计学意义。

结果

在 11830 个外周静脉导管(8200 名参与者)中,有 36%(n=4263)发生了失败。渗透/阻塞的发生率为 23%(n=2767),静脉炎为 12%(n=1421),导管脱落为 7%(n=779)。与失败和并发症显著相关的患者因素包括:女性(静脉炎;HR 1.98,95%CI 1.72-2.27)、(渗透/阻塞;HR 1.45,95%CI 1.33-1.58)、(失败;HR 1.36,95%CI 1.26-1.46);每年年龄增加(静脉炎;0.99 HR,95%CI 0.98-0.99)、(失败;0.99 HR,95%CI 0.99-0.99)。最强的提供者风险因素是静脉内抗生素(渗透/阻塞;HR 1.40,95%CI 1.27-1.53)、(静脉炎;HR 1.36,95%CI 1.18-1.56)、(失败;HR 1.26,95%CI 1.17-1.36)。由血管通路团队插入的导管脱落的可能性较小(HR 0.53,95%CI 0.42-0.67)。与所有原因失败最相关的设备风险因素是手腕/手部(HR 1.34,95%CI 1.23-1.46)、肘窝外周静脉导管(HR 1.29,95%CI 1.16-1.44)和 22/24 号导管(HR 1.27,95%CI 1.12-1.45)。

结论

确定的因素,包括血管通路团队插入的保护作用,以及与静脉内抗生素给药相关的高导管失败率,将允许外周静脉导管指南和护理模式的有针对性更新。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验